Noninvasive and invasive bladder cancer. Diagnostics and treatment;Nichtinvasives und invasives harnblasenkarzinom. Diagnostik und therapie

Urologe - Ausgabe A

Volumn 45, Issue 7, 2006, Pages 873-885

  Goebell, P J ^a,b,j   Vom Dorp, F ^a,b   Rodel C ^c   Frohneberg, D ^d   Thuroff J W ^e   Jocham, D ^f   Stief, C ^g   Roth, S ^h   Knuchel R ⁱ   Schmidt, K W ^a,b   Kausch, I ^f   Zaak, D ^g   Wiesner, C ^e   Miller, K ^b   Sauer, R ^c   Rubben H ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Westdeutsches Tumorzentrum Essen ^*

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h HELIOS KLINIKUM WUPPERTAL   (Germany)

ⁱ UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Carcinoma in situ; Chemotherapy; Cystectomy; High grade bladder cancer; Low grade bladder cancer

Indexed keywords

BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CYSTECTOMY; DIAGNOSTIC TEST; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; REVIEW; TRANSURETHRAL RESECTION; URINARY DIVERSION;

ANTINEOPLASTIC AGENTS; CYSTECTOMY; HUMANS; NEOPLASM INVASIVENESS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 33746238179     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-006-1065-z     Document Type: Review

References (14)

1. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 48: 189-199
2. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48: 202-205
3. Glas AS, Roos D, Deutekom M et al. (2003) Tumor markers in the diagnosis of primary bladder cancer. A systemic review. J Urol 169: 1975-1982
4. Gschwend JE, Dahm P, Fair WR (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41: 440-448
5. Halling KC, King W, Sokolova IA (2002) A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion for the detection of urothelial carcinoma in urine. J Uro 167: 2001-2006
6. Herr HW, Donat SM, Dalbagni G (2002) Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. J Urol 168: 978-980
7. Lamm DL, Blumenstein BA, Crissman JD et al. (2000) Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163(4): 1124-1129
8. Madersbacher S, Hochreiter W, Burkhard et al. (2003) Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 21: 690-696
9. Rodel C, Weiss C, Sauer R (2005) Organ preservation by combined modality treatment in bladder cancer: the European perspective. Semin Radiat Oncol 15: 28-35
10. Schroeder GL, Lorenzo Gomez MF et al. (2004) A side-by-side comparison of cytology and biomarkers, HA-HAse, hematuria detection, BTA STAT, UBC-Rapid for bladder cancer detection. J Urol 172: 1123-1126
11. Shipley WU, Zietman AL, Kaufman DS et al.(2005) Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates - the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 15: 36-41
12. Stein JP, Lieskovsky G, Cote R et al. (2001 ) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666-675
13. van der Meijden AP, Sylvester RJ, Oosterlinck W et al. (2003) Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial. Eur Urol 44(4): 429-434
14. Zhao J, Richter J, Wagner U et al. (1999) Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res 59: 4685-4661